Clinical Trials Logo

Tumors That Express CA19-9 clinical trials

View clinical trials related to Tumors That Express CA19-9.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04883775 Active, not recruiting - Pancreatic Cancer Clinical Trials

Study of a New Technique for Imaging Pancreatic Cancer

Start date: May 10, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to see how well the experimental imaging agent 89Zr-DFO-HuMab-5B1 attaches to pancreatic tumors, and to find out whether PET/CT scans done with this imaging agent produce better images of cancer.